FEBUXOSTAT

FEBUXOSTAT

Product Details:

  • HS Code 29420090
  • Molecular Weight 316.374 Grams (g)
  • Storage Room Temperature
  • Molecular Formula C16H16N2O3S
  • Taste Other
  • Smell No Smell
  • CAS No 144060-53-7
  • Supply Ability : 10 Kilograms Per Day
9500.00 - 10500.00 INR/Kilograms
X

Price And Quantity

  • 9500.00 - 10500.00 INR/Kilograms
  • 10 Kilograms

Product Specifications

  • No Smell
  • Other
  • C16H16N2O3S
  • it is used as a treat goutdue to high uric acid. FEBUXOSTAT is use in Pharmaceutical Formulation for the treatment of chronic gout and hyperuricemia.
  • 99
  • Medicine Grade
  • Room Temperature
  • 144060-53-7
  • Powder
  • Other
  • 316.374 Grams (g)
  • Powder
  • 99
  • 29420090

Trade Information

  • NhavaSheva By Sea and Sahar Airport By Air
  • Paypal, Western Union, Telegraphic Transfer (T/T), Letter of Credit at Sight (Sight L/C), Letter of Credit (L/C), Delivery Point (DP), Days after Acceptance (DA), Cheque, Cash in Advance (CID), Cash Advance (CA), Cash on Delivery (COD), Cash Against Delivery (CAD)
  • 10 Kilograms Per Day
  • 7 Days
  • Contact us for information regarding our sample policy
  • HDPE drum with inner LPDE liners
  • Africa, Middle East, Western Europe, Eastern Europe, South America, North America, Central America, Australia, Asia
  • West Bengal, Uttarakhand, Uttar Pradesh, Tripura, Telangana, Tamil Nadu, Sikkim, Rajasthan, Pondicherry, Punjab, Odisha, Nagaland, Manipur, Meghalaya, Mizoram, Maharashtra, Madhya Pradesh, Lakshadweep, Kerala, Karnataka, Jharkhand, Jammu and Kashmir, Himachal Pradesh, Haryana, Goa, Gujarat, Daman and Diu, Dadra and Nagar Haveli, Delhi, Chandigarh, Chhattisgarh, Bihar, Arunachal Pradesh, Assam, Andhra Pradesh, Andaman and Nicobar Islands, West India, East India, North India, Central India, South India, All India

Product Description

is availablein micronize as well as Non Micronized forms. Febuxostat is available in IP, BPand EP. Dayaram Pharma Chem isleading Manufacturer, Exporter, Distributor, and Supplier of FebuxostatAPIin HimachalPradesh, Jammu & Kashmir, Punjab, Chandigarh, Uttarakhand, Assam,Jharkhand, West Bengal, Kerala, Odisha, Chhattisgarh, Telangana, Delhi, UttarPradesh, Haryana, Manipur, Gujarat, Andhra Pradesh, Maharashtra, Bihar, TamilNadu, Karnataka, Madhya Pradesh and Rajasthan.

2-(3-cyano-4-isobutoxyphenyl)-4-methyl-1, 3-thiazole-5-carboxylic acid

Febuxostat sold under the brand name Uloricand Adenuric, is a medicine used long term to treat gout due to high uric acidlevels. When initially started medications such as NSAIDs are often recommendedto prevent gout flares. This medicine is generally suggested only for peoplewho cannot take allopurinol. It is taken by mouth. 

Side Effects:

Generally nausea may occur. It may rarely causeserious liver problem, increase in liver enzymes. Your doctor will order bloodtests to measure these enzymes. Keep lab or medical appointment. Share todoctor urgently if develop symptoms of liver disease also nausea that doesn’tstop stomach or abdominal pain, dark urine yellowing eyes and skin. Remember thatdoctor has prescribed this medication because they judged that thebenefit to you is greater than the side effects risks. Many people using thismedication do not have serious side effects. Also read warning sections. A veryserious allergic reactions to this drug is rare. Get medical help right away ifnotice any serious symptoms fever, swelling, itching, severe dizziness andtrouble breathing. This is not a complete list of possible side effects. If younotice other effects not listed above share to doctor or pharmacist.

 

 

 

 

Precaution should totake:

 

Beforeusing Febuxostat tell to doctor about medical history such as cancer, heartproblems, kidney problem, stroke, heart attack and organ transplant. Beforetaking this medicine share to doctor if you are allergic to it or if you areany other allergies. This medicine may contain inactive ingredients which cancause allergic reactions or other problems. Tell your doctor or  about all the products you use before having surgery. It is unknownif Febuxostat passes into breast milk. Share to doctor before breast-feeding. Duringpregnancy this medicine should be used only when clearly needed and advised bydoctor. Contact doctor or pharmacist for more information.

 

Overdose:

 

Ifsomeone has overdosed and has serious symptoms such as passing out or troublebreathing, Contact doctor immediately. If you missed a dose take it as soon aspossible remember. If it is near next dose skip missed one. Do not take doubledose to cover up. Take the doses daily same time to remember.

 

Notes:

 

Lab and/or medical tests such as uricacid blood level, liverfunction tests it may be done while you are taking thismedication. Keep all medical and lab appointments. Contact doctor for moredetails. Do not share this medicine with others without doctor advice.

CDSCO APPROVAL:

FebuxostatTablets 80mg / 120mg Each film coated tablet contains; febuxostat-80mg, 120mgin 18/11/09

Febuxostat40mg (Additional Strength) in 16/01/10

Formulation Available inMarket:

FEBUCIP40MG (FEBUXOSTAT) SIZE-10 TABS/PACK (PHARMACEUTICALS MEDICINES)

 

FEBUSTAT40 MG INJ (FEBUXOSTAT)-ABOTT

 

FEBUXOSTAT(GROUP:B, SRL NO:1122

 

ZURIGTABLETS (10 PACKx30=300 TABS) EACHTABS CONT: FEBUXOSTAT 80MG

FEBUCIP40MG (FEBUXOSTAT) SIZE-10 TABS/PACK (PHARMACEUTICALS MEDICINES)

 References:

https://www.verywellhealth.com/

https://www.webmd.com/

https://examine.com/

https://www.practo.com/

https://go.drugbank.com/

https://pharmeasy.in/

https://www.1mg.com/

https://www.medplusmart.com/

https://www.healthline.com/

https://www.medicalnewstoday.com/

https://www.ndrugs.com/

https://www.drugs.com/

https://www.medindia.net/

https://www.zauba.com/


DAYARAM PHARMA CHEM

* Tips on getting accurate quotes. Please include product name, order quantity, usage, special requests if any in your inquiry.

Listen to the Code(Audio Link)


Back to top
DAYARAM PHARMA CHEM All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Ltd.(Terms of Use)
Developed and Managed by Infocom Network Ltd.